Literature DB >> 16927092

Surgical treatment and outcome of mega-hydronephrosis due to pelviureteric junction stenosis.

Yoshifumi Kato1, Atsuyuki Yamataka, Tadaharu Okazaki, Toshihiro Yanai, Geoffrey J Lane, Hiroyuki Kobayashi, Tomonosuke Someya, Yuichiro Yamashiro, Takeshi Miyano.   

Abstract

To study the surgical treatment and outcome of hydronephrosis secondary to pelviureteric junction obstruction (PUJS) that is so massive that the renal pelvis crosses over the vertebral column [mega-hydronephrosis (MH)]. Of the 40 cases of PUJS we treated over the past 5 years, 6 cases had MH secondary to PUJS (MH-PUJS) in 6 renal units and were reviewed. Incidence of MH was 15.0%. All had Anderson-Hynes dismembered pyeloplasty to treat obstructive renal pattern on technetium-99m diethylenetriaminepentaacetic acid (DTPA) scans in five and gait disturbance due to MH in one. The contralateral kidney was normal in five and dysplastic in one. Three had nephrostomy before pyeloplasty. Preoperative DTPA scans showed good renal function in four and poor in two. Plication of the entire dilated, lax renal parenchyma ("nephroplication") was performed in three to decrease the intra-renal pelvic cavity. Prenatal diagnosis was performed in three cases. Mean age at pyeloplasty was 3.5 years and mean duration of follow-up was 1.5 years. Postoperatively, two of the three who did not have nephroplication had prolonged but not obstructed renal pattern on DTPA scans, and the other case who did not have nephroplication had nephrectomy for non-functioning kidney caused by recurrent pyelonephritis 2 years after pyeloplasty. In the three who had nephroplication, DTPA scans showed acceptable to relatively good passage in all cases. The surgical treatment of MH-PUJS is challenging with no fixed guidelines. However, nephroplication may be useful during pyeloplasty to decrease the size of MH-PUJS.

Entities:  

Mesh:

Year:  2006        PMID: 16927092     DOI: 10.1007/s00383-006-1763-z

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  9 in total

1.  Hydronephrosis and giant hydronephrosis.

Authors:  W C YANG; S C SHEN; C P WU
Journal:  Chin Med J       Date:  1958-09

2.  Retrocaval ureter; a case diagnosed pre-operatively and treated successfully by a plastic operation.

Authors:  J C ANDERSON; W HYNES
Journal:  Br J Urol       Date:  1949-09

3.  Pyeloplasty in hydronephrosis: examination of surgical results from a morphologic point of view.

Authors:  R Stein; F Ikoma; S Salge; T Miyanaga; Y Mori
Journal:  Int J Urol       Date:  1996-09       Impact factor: 3.369

4.  Nephroplasty in the management of hydronephrosis.

Authors:  P J Smith; M Dunn; J B Roberts
Journal:  Br J Urol       Date:  1979-08

5.  Giant hydronephrosis in children.

Authors:  A C Uson; S B Levitt; J K Lattimer
Journal:  Pediatrics       Date:  1969-08       Impact factor: 7.124

6.  Pediatric pyleoplasty.

Authors:  W H Hendren; J Radhakrishnan; A W Middleton
Journal:  J Pediatr Surg       Date:  1980-04       Impact factor: 2.545

7.  Pelvic hydronephrosis in children: a review of 219 personal cases.

Authors:  J H Johnston; J P Evans; K I Glassberg; S R Shapiro
Journal:  J Urol       Date:  1977-01       Impact factor: 7.450

8.  Nephroplication and nephropexy as an adjunct to primary surgery in the management of giant hydronephrosis.

Authors:  A K Hemal; M Aron; S N Wadhwa
Journal:  Br J Urol       Date:  1998-05

9.  Giant hydronephrosis in children.

Authors:  K K Crooks; W H Hendren; R C Pfister
Journal:  J Pediatr Surg       Date:  1979-12       Impact factor: 2.545

  9 in total
  2 in total

Review 1.  Surgical Approaches to Pediatric Ureteropelvic Junction Obstruction.

Authors:  Ryan W Tubre; John M Gatti
Journal:  Curr Urol Rep       Date:  2015-10       Impact factor: 3.092

Review 2.  Pyeloplasty techniques using minimally invasive surgery (MIS) in pediatric patients.

Authors:  Francesco Turrà; Maria Escolino; Alessandra Farina; Alessandro Settimi; Ciro Esposito; François Varlet
Journal:  Transl Pediatr       Date:  2016-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.